Clinical Trial for Early-Stage Non-Small Cell Lung Cancer Following Surgery

Big Ten Cancer Research Consortium

24 Jun, 2020 ,

Greg Durm, MD, a medical oncologist, and researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, describes how researchers are testing if giving an immunotherapy drug called pembrolizumab following surgery is better than observation following surgery in adults with this type of cancer.

ONCOLOGY

Also Read

Knocking Out Matrix Metalloproteinase 12 Causes The Accumulation Of M2 Macrophages In Intestinal Tumor Microenvironment Of Mice

Jul 10, 2020

PD-1+ Natural Killer Cells In Human Non-Small Cell Lung Cancer Can Be Activated By PD-1/PD-L1 Blockade

Jul 10, 2020

Should Short-course Neoadjuvant Radiotherapy Be Applied for Low-lying Rectal Cancer? A Systematic Review and Meta-analysis of the Randomized Trials

Jul 10, 2020

Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation

Jul 10, 2020